Thermo Fisher Scientific Closes $3.8 Billion Offering of USD-Denominated Senior Notes

Thermo Fisher Scientific Closes $3.8 Billion Offering of USD-Denominated Senior Notes

Client News

Thermo Fisher Scientific Inc. (NYSE, TMO) announced an offering of $3.8 billion aggregate principal amount of USD denominated senior notes, consisting of $1,000,000,000 aggregate principal amount of its 4.215% Senior Notes due 2031, $750,000,000 aggregate principal amount of its 4.550% Senior Notes due 2033, $1,300,000,000 aggregate principal amount of its 4.902% Senior Notes due 2036, and $750,000,000 aggregate principal amount of its 5.546% Senior Notes due 2046. The offering priced on February 9, 2026, and closed on February 12, 2026. The joint book running managers for the offering were Deutsche Bank Securities Inc., RBC Capital Markets, LLC, SMBC Nikko Securities America, Inc., and Wells Fargo Securities, LLC.

WilmerHale advised Thermo Fisher on the transaction.

The WilmerHale team consisted of Molly Fox, Andrew Langworthy, Rachael Joseph, Amy O’Connell, and Madeline Gatto (Capital Markets), with assistance from Meghan Walsh and Skyler Dykes (Tax).

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.